These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32259456)

  • 21. Gastrointestinal cancer organoids-applications in basic and translational cancer research.
    Seidlitz T; Stange DE
    Exp Mol Med; 2021 Oct; 53(10):1459-1470. PubMed ID: 34663939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.
    Trip AK; Stiekema J; Visser O; Dikken JL; Cats A; Boot H; van Sandick JW; Jansen EP; Verheij M
    Acta Oncol; 2015 Nov; 54(10):1754-62. PubMed ID: 25797568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
    Veuillez V; Rougier P; Seitz JF
    Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy.
    Wu W; Li X; Yu S
    Acta Biomater; 2022 Jul; 146():23-36. PubMed ID: 35533925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
    Gao J; Lan J; Liao H; Yang F; Qiu P; Jin F; Wang S; Shen L; Chao T; Zhang C; Zhu Y
    BMC Cancer; 2023 Dec; 23(1):1205. PubMed ID: 38062430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future.
    Aggelis V; Cunningham D; Lordick F; Smyth EC
    Ann Oncol; 2018 Jun; 29(6):1377-1385. PubMed ID: 29771279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids.
    Takahashi N; Hoshi H; Higa A; Hiyama G; Tamura H; Ogawa M; Takagi K; Goda K; Okabe N; Muto S; Suzuki H; Shimomura K; Watanabe S; Takagi M
    Cells; 2019 May; 8(5):. PubMed ID: 31137590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models.
    Tiriac H; French R; Lowy AM
    J Vis Exp; 2020 Jan; (155):. PubMed ID: 32009658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool.
    Obreque J; Vergara-Gómez L; Venegas N; Weber H; Owen GI; Pérez-Moreno P; Leal P; Roa JC; Bizama C
    Biol Res; 2023 Dec; 56(1):63. PubMed ID: 38041132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical oncology in the age of multimodality therapy for cancer of the upper and lower gastrointestinal tract.
    Neumann PA; Berlet MW; Friess H
    Expert Rev Anticancer Ther; 2021 May; 21(5):511-522. PubMed ID: 33355020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality treatment for localized gastro-oesophageal cancer.
    Okines AF; Cunningham D
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii286-93. PubMed ID: 20943630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.
    Chen P; Zhang X; Ding R; Yang L; Lyu X; Zeng J; Lei JH; Wang L; Bi J; Shao N; Shu D; Wu B; Wu J; Yang Z; Wang H; Wang B; Xiong K; Lu Y; Fu S; Choi TK; Lon NW; Zhang A; Tang D; Quan Y; Meng Y; Miao K; Sun H; Zhao M; Bao J; Zhang L; Xu X; Shi Y; Lin Y; Deng C
    Adv Sci (Weinh); 2021 Nov; 8(22):e2101176. PubMed ID: 34605222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development.
    Nelson SR; Zhang C; Roche S; O'Neill F; Swan N; Luo Y; Larkin A; Crown J; Walsh N
    Sci Rep; 2020 Feb; 10(1):2778. PubMed ID: 32066753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.
    Lutz MP; Zalcberg JR; Ducreux M; Adenis A; Allum W; Aust D; Carneiro F; Grabsch HI; Laurent-Puig P; Lordick F; Möhler M; Mönig S; Obermannova R; Piessen G; Riddell A; Röcken C; Roviello F; Schneider PM; Seewald S; Smyth E; van Cutsem E; Verheij M; Wagner AD; Otto F
    Eur J Cancer; 2019 May; 112():1-8. PubMed ID: 30878666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and Characterization of Patient-derived Gastric Organoids from Biopsies of Benign Gastric Body and Antral Epithelium.
    Buckley KH; Beyries KA; Ryeom S; Yoon SS; Katona BW
    J Vis Exp; 2024 Jan; (203):. PubMed ID: 38345211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation, Expansion, and Biobanking of Gastrointestinal Patient-Derived Organoids from Tumor and Normal Tissues.
    Cabeza-Segura M; Garcia-Micó B; Cervantes A; Castillo J
    Methods Mol Biol; 2024; 2777():123-133. PubMed ID: 38478340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xenograft and organoid model systems in cancer research.
    Bleijs M; van de Wetering M; Clevers H; Drost J
    EMBO J; 2019 Aug; 38(15):e101654. PubMed ID: 31282586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.